Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,396 | -12,670 | -101,052 | -76,453 | -51,771 |
| Depreciation Amortization | -12 | 3 | 752 | 1,191 | 1,101 |
| Accounts payable and accrued liabilities | -2,201 | -567 | 194 | 1,275 | 883 |
| Other Working Capital | 715 | -289 | -7,208 | -4,655 | -2,304 |
| Other Operating Activity | 2,572 | 725 | 19,334 | 13,091 | 8,757 |
| Operating Cash Flow | $-26,322 | $-12,798 | $-87,980 | $-65,551 | $-43,334 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -6 | -6,594 | -5,573 | -4,658 |
| Purchase Of Investment | -26,851 | N/A | -405,519 | -339,814 | -254,225 |
| Sale Of Investment | N/A | 0 | 170,250 | 90,000 | N/A |
| Investing Cash Flow | $-26,881 | $-6 | $-241,863 | $-255,387 | $-258,883 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83,179 | 203 | 676 | 432 | 427 |
| Common Stock Repurchased | N/A | N/A | -79 | -79 | -15 |
| Other Financing Activity | 0 | 82,976 | 0 | 0 | 0 |
| Financing Cash Flow | $83,179 | $83,179 | $597 | $353 | $412 |
| Beginning Cash Position | 44,441 | 44,441 | 378,692 | 378,692 | 378,692 |
| End Cash Position | 74,417 | 114,816 | 49,446 | 58,107 | 76,887 |
| Net Cash Flow | $29,976 | $70,375 | $-329,246 | $-320,585 | $-301,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,322 | -12,798 | -87,980 | -65,551 | -43,334 |
| Capital Expenditure | -30 | -6 | -6,594 | -5,573 | -4,658 |
| Free Cash Flow | -26,352 | -12,804 | -94,574 | -71,124 | -47,992 |